Skip to content

Embecta Corp. EMBC EBITDA margin

EBITDA margin at other companies

Insulet logo
InsuletPODD
20.8%+1.5pp
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-6.4%-2.4pp
Medtronic logo
MedtronicMDT
25.9%-0.4pp
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
-12.2%
Mannkind logo
MannkindMNKD
25.9%+3.3pp
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
-68.4%-6.4pp

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Calculated from Embecta Corp.’s reported figures.

Based on trailing twelve months.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s EBITDA margin?
Embecta Corp. (EMBC) reported EBITDA margin of 29.9% in Q1 2026.
How has Embecta Corp.'s EBITDA margin changed year-over-year?
Embecta Corp.'s EBITDA margin increased by 53.3% year-over-year, from 19.5% to 29.9%.
What is the long-term trend for Embecta Corp.'s EBITDA margin?
Over 4 years (2021 to 2025), Embecta Corp.'s EBITDA margin has grown at a -12.9% compound annual growth rate (CAGR), from 45.5% to 26.2%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.